81
Participants
Start Date
June 30, 2011
Primary Completion Date
December 6, 2018
Study Completion Date
December 6, 2018
Gemcitabine
2775 mg/m2 by vein over about 3 hours on days -8 and -3.
Busulfan
"32 mg/m2 test dose with PKs as outpatient and on day -10 as inpatient~AUC 4,000 by vein over about 3 hours on days -8 to -5."
Melphalan
60 mg/m2 by vein over about 30 minutes on days -3 and -2.
Stem Cell Transplantation
Infusion of stem cells on Day 0.
Palifermin
60 mg/kg by vein over 30 seconds daily, Days -12 to -10 and Days 0 to 2.
University of Texas MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER